Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Brain deterioration resulting from "protein folding" diseases, such as the Alzheimer's disease (AD), is one of the leading causes of morbidity and mortality in the aging human population. Heat shock proteins (Hsps) constitute the major cellular quality control system for proteins that mitigates the pathological burden of neurotoxic protein fibrils and aggregates. However, the therapeutic effect of Hsps has not been tested in a relevant setting. Here we report the dramatic neuroprotective effect of recombinant human Hsp70 in the bilateral olfactory bulbectomy model (OBX mice) and 5XFAD mouse models of neurodegeneration. We show that intranasally-administered Hsp70 rapidly enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animals. In particular, in both cases it normalizes the density of neurons in the hippocampus and cortex which correlates with the diminished accumulation of amyloid-β (Aβ) peptide and, in the case of 5XFAD mice, reduces Aβ plaque formation. Consistently, Hsp70 treatment also protects spatial memory in OBX and 5XFAD mice. These studies demonstrate that exogenous Hsp70 may be a practical therapeutic agent for treatment of neurodegenerative diseases associated with abnormal protein biogenesis and cognitive disturbances, such as AD, for which neuroprotective therapy is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 1×
“E-mail: evgeny.nudler@nyumc.org. neurons, including the quantity of neurofibrillary tangles , the decrease in synaptic density, the enhanced concentration of soluble amyloid- (A) oligomers, and the amount of neurons that die by apoptosis [1] [2] [3].”
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“It is likely that the level of soluble A and its aggregates are mostly responsible for the cytotoxicity [37].”
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 5×
“In contrast to OBX animals, they are characterized by a high level of amyloid plaques that appear early in their lifespan in different brain regions [12].”
MethodInfluentialAlzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“Thus it was demonstrated that intracellular accumulation of A is an early event in neuronal dysfunction [38] and cytosolic A has been shown to be highly cytotoxic to primary neurons [39].”
The olfactory bulbectomised rat as a model of depression
Song, C., & Leonard, B. E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.010 · Cited by 698 · cited 1×
“OBX animals exhibit functional, morphological, and biochemical characteristics similar to those described for AD patients [2, 17, 18], including severe memory loss [11, 13–16].”
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697 · cited 1×
“Precise mechanisms providing such transport are not known and may involve neuron terminals, bulk flow and diffusion within perineuronal channels, perivascular spaces, or lymphatic channels directly connected to brain tissue [36].”
Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey II, W. H., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13309 · Cited by 521 · cited 1×
“Thus, intranasal administration of insulin was found effective to modulate verbal memory and plasma A in memory-impaired older adults and in other model systems [48, 49].”
Cummings, C. J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1511 · Cited by 485 · cited 1×
“Several observations demonstrate that chaperones belonging to Hsp70 family can ameliorate cellular toxicity of aberrantly folded proteins extant in AD, Parkinson’s disease, amyotrophic lateral sclerosis, and polyQ-diseases [4, 34, 35], suggesting that treatment with Hsp70 could potentially be therapeutic for these dev…”
Research works printed but not linked: 4
- [2][2] Reisberg B, Saeed MU (2004) Alzheimer's disease. In Comprehensive Textbook of Geriatric Psychiatry, 3rd edition, Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. WW Norton, New York, pp. 449-509. -
- [11][11] Bobkova NV, Nesterova I, Medvinskaya N, Samokhin A, Alexandrova I (2005) Possible role of the olfactory system in Alzheimer's disease genesis. In New Trends in Alzheimer and Parkinson Disorders: ADPD 2005 , Fisher A, Hanin I, Memo M, Stocchi F, eds. Medimond, Sorento, pp. 91-95. -
- [20][20] Wilson MC, et al. (1994) Regulation of the olfactory bulb Alzheimer's precursor protein (APP) by lesioning of the olfactory bulb. Soc Neurosci 509 (8), 1249. -
- [34][34] Margulis B, Kinev A, Guzhova I (2006) Chaperones in neurodegenerative pathologies: Therapeutic prospects. In Heat Shock Proteins in Biology and Medicine , Radons J, Multhoff G, eds. Research Signpost, Kerala, pp. 305-329. -
Cited by
Regulation of heat shock transcription factors and their roles in physiology and disease
Gomez-Pastor, R., Burchfiel, E. T., & Thiele, D. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.73 · Cited by 849
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“HSP70 (34) HSP70 helps client proteins fold correctly and are pivotal to maintaining cellular integrity”
BackgroundInfluentialNeurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Hussain, R., Zubair, H., Pursell, S., & Shahab, M. (2018) · Brain Sciences · doi:10.3390/brainsci8090177 · Cited by 229
“In a recent study, intranasal administration of Hsp70 was reported to improve cognitive deficits in AD like pathology in the mice model [154], possibly by reducing the production of reactive oxygen species [155].”
BackgroundMechanisms tailoring the expression of heat shock proteins to proteostasis challenges
Alagar Boopathy, L. R., Jacob-Tomas, S., Alecki, C., & Vera, M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101796 · Cited by 174
Luca, M., Luca, A., & Calandra, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/504678 · Cited by 175
“Hsp90 inhibitors, through the activation of HSF-1, exert neuroprotective effects favouring the induction of Hsps, such as Hsp70 [93, 98], that has been found to exert therapeutic properties in mice with AD [99].”
BackgroundBehavioral and EEG changes in male 5xFAD mice
Schneider, F., Baldauf, K., Wetzel, W., & Reymann, K. G. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.05.041 · Cited by 169
Heat-Shock Proteins in Neuroinflammation
Dukay, B., Csoboz, B., & Tóth, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00920 · Cited by 133
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
Gadhave, K., Bolshette, N., Ahire, A., Pardeshi, R., Thakur, K., Trandafir, C., Istrate, A., Ahmed, S., Lahkar, M., Muresanu, D. F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12817 · Cited by 119
Exogenous Hsp70 delays senescence and improves cognitive function in aging mice
Bobkova, N. V., Evgen’ev, M., Garbuz, D. G., Kulikov, A. M., Morozov, A., Samokhin, A., Velmeshev, D., Medvinskaya, N., Nesterova, I., Pollock, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516131112 · Cited by 118
“This finding confirms our previous data demonstrating significantly higher neuronal density in brain regions of eHsp70-treated 5XFAD mice compared with control mice (23).”
BackgroundResultInfluentialSelf-citationHeat Shock Protein 70 in Alzheimer’s Disease
Lu, R.-C., Tan, M., Wang, H., Xie, A., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/435203 · Cited by 117
“Recently, intranasally administered HSP70 rapidly enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animals [12].”
BackgroundGarbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2021) · Molecular Biology · doi:10.1134/s002689332104004x · Cited by 103
Self-citationHeat shock proteins: a therapeutic target worth to consider
Dubey, A., Prajapati, K. S., Swamy, M., & Pachauri, V. (2015) · Veterinary World · doi:10.14202/vetworld.2015.46-51 · Cited by 96
“Overexpression of HSP70 in Drosophila model of Parkinson disease and 5XFAD mouse model of Alzheimer disease delayed the progression of disease by autophagy of misfolded proteins and reduction of caspase-3 induced cell death [6,29,30].”
BackgroundZatsepina, O. G., Evgen’ev, M. B., & Garbuz, D. G. (2021) · Cells · doi:10.3390/cells10071638 · Cited by 83
“Models of bulbectomized mice that develop all major manifestations of AD a few months after surgical removal of the olfactory bulbs are also considered to be valid [142,162,163].”
BackgroundMethodSelf-citationYang, G., Gong, C., Zheng, X., Hu, F., Liu, J., Wang, T., Chen, X., Li, M., Zhu, Z., Zhang, L., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122406 · Cited by 86
Wang, B., Liu, Y., Huang, L., Chen, J., Li, J. J., Wang, R., Kim, E., Chen, Y., Justicia, C., Sakata, K., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.104 · Cited by 67
Zelaya, M. V., Pérez-Valderrama, E., de Morentin, X. M., Tuñon, T., Ferrer, I., Luquin, M. R., Fernandez-Irigoyen, J., & Santamaría, E. (2015) · Oncotarget · doi:10.18632/oncotarget.6254 · Cited by 67
“com/oncotarget administered of recombinant human HSP70 in murine models of AD has demonstrated dramatic neuroprotective effects [48], suggesting that our experimental workflow is a useful approach to detect and identify practical therapeutic agents for AD treatment.”
New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson's disease
Ekimova, I. V., Плаксина, Д. В., Pastukhov, Y. F., Lapshina, K. V., Lazarev, V. F., Mikhaylova, E. R., Полоник, С. Г., Pani, B., Margulis, B. A., Guzhova, I. V., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.04.012 · Cited by 79
Self-citationAnti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies
Nakajima, A., Ohizumi, Y., & Yamada, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.75 · Cited by 64
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer’s Disease
Mamun, A. A., Uddin, M. S., Kabir, M. T., Khanum, S., Sarwar, M. S., Mathew, B., Rauf, A., Ahmed, M., & Ashraf, G. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00185-1 · Cited by 68
Hsp60, amateur chaperone in amyloid-beta fibrillogenesis
Mangione, M. R., Vilasi, S., Mariño, C., Librizzi, F., Canale, C., Spigolon, D., Bucchieri, F., Fucarino, A., Passantino, R., Cappello, F., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.019 · Cited by 63
Engineering therapeutic protein disaggregases
Shorter, J. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-10-0693 · Cited by 54
“Several other studies suggest that exogenous delivery of Hsp70 can have beneficial, neuroprotective effects in mice (Nagel et al., 2008; Bobkova et al., 2014; Bobkova et al., 2015).”
BackgroundLin, M., Zhao, D., Hrabovsky, A., Pedrosa, E., Zheng, D., & Lachman, H. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094968 · Cited by 53
“novel therapeutic strategy [83–86].”
Vorobyov, V., Kaptsov, V., Gordon, R. Y., Makarova, E. G., Podolski, I. Y., & Sengpiel, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142469 · Cited by 49
“Transgenic animal models of AD may facilitate a breakthrough in the understanding of disease mechanisms [8–11].”
Ying, G., Jing, C., Li, J., Wu, C., Yan, F., Chen, J.-Y., Wang, L., Dixon, B. J., & Chen, G. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001264 · Cited by 47
The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity
Jarvela, T. S., Lam, H. A., Helwig, M., Lorenzen, N., Otzen, D. E., McLean, P. J., Maidment, N. T., & Lindberg, I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601091113 · Cited by 46
“DMSO + vehicle DMSO + proSAAS (1-180) Geldanamycin (50nM) + vehicle )ua( ecnseroulF sneV C”
BackgroundMuronetz, V. I., Barinova, K. V., Stroylova, Y. Y., Semenyuk, P. I., & Schmalhausen, E. V. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.066 · Cited by 47
Kasza, Á., Hunya, Á. G., Frank, Z., Fülöp, F., Török, Z., Balogh, G. E., Sántha, M., Bálind, Á., Bernáth, S., Blundell, K. L. I. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150860 · Cited by 46
“Exogenous human Hsp70 had dramatic neuroprotective effects in olfactory bulbectomy mice and 5xFAD mouse models of neurodegeneration [29] based on its anti-apoptotic and anti-inflammatory effects.”
BackgroundEvgen’ev, M. B., Krasnov, G. S., Nesterova, I. V., Garbuz, D. G., Карпов, В. Л., Morozov, A. V., Snezhkina, A. V., Samokhin, A. N., Sergeev, A., Куликов, А. М., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170398 · Cited by 58
“We showed that intranasally administered Hsp70 rapidly enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animals [17, 38].”
InfluentialSelf-citationExtracellular heat shock proteins in neurodegenerative diseases: New perspectives
Lyon, M. S., & Milligan, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134462 · Cited by 45
Closest horizons of Hsp70 engagement to manage neurodegeneration
Venediktov, A. A., Bushueva, O. Y., Kudryavtseva, V. A., Kuzmin, E. A., Moiseeva, A. V., Baldycheva, A. V., Meglinski, I. V., & Piavchenko, G. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1230436 · Cited by 45
“Further, mice with familial AD display declined A β levels and partial cognitive recovery after rHsp70ex administration (Bobkova et al., 2014; Evgen'ev et al., 2017).”
Almeida, R. F., Ganzella, M., Machado, D. G., Loureiro, S. O., Leffa, D. T., Quincozes‐Santos, A., Pettenuzzo, L. F., Duarte, M. M. M. F., Duarte, T., & Souza, D. O. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.013 · Cited by 47
“Some authors postulate that the cognitive phenotype induced by OBX (loss of spatial memory), accompanied by increased brain levels of tau-protein hyperphosphorylation, could be associated as a model for Alzheimer ́s disease (Bobkova et al., 2014; Hu et al., 2012).”
BackgroundMorozov, A. V., Astakhova, T. M., Garbuz, D. G., Krasnov, G. S., Bobkova, N. V., Zatsepina, O. G., Карпов, В. Л., & Evgen’ev, M. B. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0792-y · Cited by 41
Self-citationModulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70
Rivera, I., Capone, R. F., Cauvi, D. M., Arispe, N. J., & Maio, A. D. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0839-0 · Cited by 41
HSP70 Facilitates Memory Consolidation of Fear Conditioning through MAPK Pathway in the Hippocampus
Porto, R. R., Dutra, F. D., Crestani, A. P., Holsinger, R. M. D., Quillfeldt, J. A., de Bittencourt, P. I. H., & Alvares, L. D. O. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.028 · Cited by 39
Secreted endogenous macrosomes reduce Aβ burden and ameliorate Alzheimer’s disease
Wang, C., Yang, Y., Zhang, X., Shi, Z., Gao, H., Zhong, M., Fan, Y., Zhang, H., Liu, B., & Qing, G. (2023) · Science Advances · doi:10.1126/sciadv.ade0293 · Cited by 42
“Five kinds of proteins (table S5), including HSP70 member ( HSPA1B ) ( 47 , 48 ), laminin subunit gamma-1 ( LAMC1 ) ( 49 ), basigin ( BSG , known as CD147) ( 50 ), protein disulfide-isomerase ( P4HB ) ( 51 ), and HSP90 ( HSP90AB1 ) ( 47 ), have already been reported to inhibit Aβ aggregation and…”
Roe, S. M., Wahab, B., Török, Z., Horváth, I., Vígh, L., & Prodromou, C. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00051 · Cited by 36
“Molecular chaperones together with the ubiquitinproteasome system represent a means by which misfolded proteins in AD could be targeted for clearance (Sulistio and Heese, 2016) and some heat shock proteins show neuroprotective action in vivo, (Liu et al., 2009; Manaenko et al., 2010; West et al., 2012; Doyle et al., 2…”
BackgroundMethodThe Y-Box Binding Protein 1 Suppresses Alzheimer’s Disease Progression in Two Animal Models
Бобкова, Н. В., Lyabin, D. N., Medvinskaya, N. I., Samokhin, A. N., Nekrasov, P. V., Nesterova, I. V., Aleksandrova, I. Y., Tatarnikova, O. G., Bobylev, A. G., Vikhlyantsev, I. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138867 · Cited by 38
“As known, both YB-1 and Hsp70 are stress proteins responsible for normal functioning of other proteins: Hsp70 acts as a chaperone, and YB-1 protects nucleus machinery under stress conditions [33].”
BackgroundMethodResultInfluentialSelf-citationProteostasis in neurodegenerative diseases
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.002 · Cited by 36
Sun, Y., Zhang, J., & Chen, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5253 · Cited by 43
“In addition, neuroprotective activities of HSP70 regarding the anti-aggregation and initiation of A β clearance have been reported (19), suggesting that inducers of HSP70 may be potential therapeutic targets in the treatment of AD.”
InfluentialEvgen’ev, M. B., Bobkova, N. V., Krasnov, G. S., Garbuz, D. G., Funikov, S. Y., Kudryavtseva, A. V., Куликов, А. М., Samokhin, A. N., Maltsev, A. V., & Nesterova, I. V. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180987 · Cited by 33
“The illustrations of the mentioned pathologies and normal healthy neurons have been previously published [3, 7].”
Self-citationImpact of Heat Shock Proteins in Neurodegeneration: Possible Therapeutical Targets
Beretta, G., & Shala, A. L. (2022) · Annals of Neurosciences · doi:10.1177/09727531211070528 · Cited by 32
The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
Bobkova, N. V., & Vorobyov, V. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.156954 · Cited by 31
“Depleting level of a presynaptic marker, synaptophysin, closely associated with lowering of synaptic receptor density in both AD patients, transgenic animals and OBX-mice (Bobkova et al., 2014b), has been shown to be compensated in part by enhancing level of a postsynaptic protein, PSD-95 (Leuba et al., 2008).”
BackgroundSelf-citationInducible HSP70 Is Critical in Preventing the Aggregation and Enhancing the Processing of PMP22
Chittoor-Vinod, V. G., Lee, S., Judge, S. M., & Notterpek, L. M. (2015) · ASN NEURO · doi:10.1177/1759091415569909 · Cited by 35
“For example, HSP70 has been shown to reduce protein aggregation and alleviate disease phenotypes in various neurodegenerative disorders, including Alzheimer’s disease (Bobkova et al., 2014), amyotrophic lateral sclerosis (Gifondorwa et al., 2012), and tauopathies (Jinwal et al., 2013).”
BackgroundHeat Shock Proteins at the Crossroads between Cancer and Alzheimer’s Disease
Wang, H., Tan, M., Lu, R.-C., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/239164 · Cited by 39
“Previous studies have showed that the functional disorder of Hsp70 related to neuroprotective system play an important role in development of AD [78], and intranasally administered Hsp70 enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animal…”
BackgroundYurinskaya, M. M., Krasnov, G. S., Kulikova, D. A., Zatsepina, O. G., Винокуров, М. Г., Chuvakova, L. N., Rezvykh, A. P., Funikov, S. Y., Morozov, A. V., & Evgen’ev, M. B. (2020) · Inflammation Research · doi:10.1007/s00011-020-01329-x · Cited by 31
“Surprisingly, similar to our data accumulated in studies that investigated the consequences of sub-chronic intranasal administration of eHsp70 [10, 11], analogous NaHS treatment was found to enhance learning and memory of aged mice, which was measured through behavioral tests [8, 12].”
ResultSelf-citationExogenous recombinant Hsp70 mediates neuroprotection after photothrombotic stroke
Demyanenko, S. V., Nikul, V. V., Rodkin, S., Davletshin, A. I., Evgen’ev, M. B., & Garbuz, D. G. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01159-0 · Cited by 29
Self-citationHsp70 affects memory formation and behaviorally relevant gene expression in Drosophila melanogaster
Zatsepina, O. G., Nikitina, E. A., Shilova, V. Y., Chuvakova, L. N., Sorokina, S. Y., Vorontsova, Y. E., Tokmacheva, E. V., Funikov, S. Y., Rezvykh, A. P., & Evgen’ev, M. B. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01203-7 · Cited by 32
Self-citationFroestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 32
Recombinant HSP70 and mild heat shock stimulate growth of aged mesenchymal stem cells
Andreeva, N. V., Zatsepina, O. G., Garbuz, D. G., Evgen’ev, M. B., & Belyavsky, A. V. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0691-7 · Cited by 32
Self-citationMolecular chaperones biochemistry and role in neurodegenerative diseases
Châari, A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.148 · Cited by 33
(Bio)chemical Strategies To Modulate Amyloid-β Self-Assembly
Ayala, S., Genevaux, P., Hureau, C., & Faller, P. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00239 · Cited by 33
Yurinskaya, M. M., Mitkevich, V. A., Kozin, S. A., Evgen’ev, M. B., Makarov, A. А., & Винокуров, М. Г. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.336 · Cited by 27
Self-citationChaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
Воронин, М. В., Абрамова, Е. В., Verbovaya, E. R., Vakhitova, Y. V., & Середенин, С. Б. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010823 · Cited by 31
“This result is consistent with the neuroprotective effect of recombinant human Hsp70 in the bilateral olfactory bulbectomy and 5XFAD mouse models of AD [448].”
ResultThe development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice
Gurskiy, Y. G., Garbuz, D. G., Soshnikova, N. V., Краснов, А. Н., Deykin, A. V., Lazarev, V. F., Sverchinsky, D. V., Margulis, B. A., Zatsepina, O. G., Карпов, В. Л., et al. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0729-x · Cited by 24
“However, it may come out from the cell via unusual mechanisms, different from regular secretory process (Multhoff and Hightower 1996; De Maio 2014; Fleshner and Johnson 2005).”
BackgroundMethodInfluentialSelf-citationHsp70 ameliorates sleep deprivation-induced anxiety-like behavior and cognitive impairment in mice
Kang, Z., Lin, Y., Su, C., Li, S., Xie, W., & Wu, X. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110791 · Cited by 24
“Moreover, chronic Hsp70 therapy improved a number of behavioral and biochemical abnormalities in two models of AD (Bobkova et al., 2014).”
Chaperones vs. oxidative stress in the pathobiology of ischemic stroke
Soldatov, V. O., Venediktov, A. A., Белых, А. Е., Piavchenko, G. A., Naimzada, M. D., Ogneva, N., Kartashkina, N. L., & Bushueva, O. Y. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1513084 · Cited by 24
Пази, М. Б., Belan, D. V., Komarova, E. Y., & Ekimova, I. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073951 · Cited by 23
“After intranasal administration, human recombinant HSP70 demonstrates therapeutic effects in animal models of PD and Alzheimer’s disease [53,54].”
BackgroundLiu, L., Zhang, C., Kalionis, B., Wan, W., Murthi, P., Chen, C., Li, Y., & Xia, S. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.003 · Cited by 20
Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates
Lazarev, V. F., Mikhaylova, E. R., Guzhova, I. V., & Margulis, B. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00277 · Cited by 21
Semenyuk, P. I., Kurochkina, L. P., Barinova, K. V., & Muronetz, V. I. (2020) · Polymers · doi:10.3390/polym12030517 · Cited by 17
“The therapeutic effect of Hsp70 has also been shown for Alzheimer’s disease [17].”
BackgroundGarbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2019) · Molecular Biology · doi:10.1134/s0026893319020055 · Cited by 18
Self-citationKanouchi, H., Kakimoto, T., Nakano, H., Suzuki, M., Nakai, Y., Shiozaki, K., Akikoka, K., OTOMARU, K., Nagano, M., & Matsumoto, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150796 · Cited by 21
“revealed that exogenous HSP70 inhibited the accumulation of amyloid β and cognitive abnormalities in a mouse model of AD [21].”
BackgroundRibeiro, C. T., Peixoto, D. O., Santos¹, L. F. D. S., Girardi, C. S., Brum, P. O., Kessler, F. G. C., Somensi, N., Behrens, L. M. P., Bittencourt, R. R., Soares, L. S., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100253 · Cited by 22
Encapsulated Hsp70 decreases endotoxin-induced production of ROS and TNFα in human phagocytes
Yurinskaya, M. M., Kochetkova, O. Y., Shabarchina, L. I., O.Yu., A., Сусликов, А. В., Евгеньев, М. Б., & Vinokurov, M. G. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0743-z · Cited by 17
“The usefulness of exogenously produced or artificially induced Hsp70 has been demonstrated in several model systems accompanied by inflammation (Ekimova et al. 2010; Hoshino 2011; Bobkova et al. 2014; Bobkova et al. 2015).”
Hu, Z., Yang, J., Zhang, S., Li, M., Zuo, C., Mao, C., Zhang, Z., Tang, M., Shi, C., & Xu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01277 · Cited by 16
“Elevated HSP70 is associated with protection in the brains of AD transgenic mice (Bobkova et al., 2014).”
BackgroundWalker, A. C., Bhargava, R., Bucher, M. J., Argote, Y. M., Brust, A. S., & Czyż, D. M. (2024) · iScience · doi:10.1016/j.isci.2024.110828 · Cited by 15
Kwon, H. J., Kim, W., Jung, H. Y., Kang, M. S., Kim, J. W., Hahn, K. R., Yoo, D. Y., Yoon, Y. S., Hwang, I. K., & Kim, D. W. (2019) · Laboratory Animal Research · doi:10.1186/s42826-019-0020-2 · Cited by 16
“protects neurons from damage due to energy deprivation [45], Alzheimer’s disease [46], and epilepsy [47].”
BackgroundStepanichev, M. Y., Markov, D. A., Pasikova, N. V., & Gulyaeva, N. V. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.033 · Cited by 14
Peña‐Ortega, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160928151546 · Cited by 18
“In fact, all these TLR4 regulators have been shown to alter synaptic transmission and its plasticity [82, 77-80].”
Yurttaş, C., Schmitz, C., Turgut, M., Strekalova, T. V., & Steinbusch, H. W. M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.07.010 · Cited by 16
“Epidemiological studies demonstrated an association between traumatic brain injury and development of AD and AD-like pathology induced by OBX (Bobkova et al., 2014a).”
BackgroundResultAlfalfa-derived HSP70 administered intranasally improves insulin sensitivity in mice
Tytell, M., Davis, A., Giles, J. M., Snider, L. C., Xiao, R., Dozier, S., Presley, T. D., & Kavanagh, K. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0835-4 · Cited by 14
Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer’s Disease in Mouse Model
Kiris, İ., Karayel‐Basar, M., Şahin, B., Gürel, B., Coşkun, J., Mroczek, T., & Baykal, A. T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999201116193126 · Cited by 15
Cao, L., & Sun, Z. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s354022 · Cited by 13
“Hsp70 may play a therapeutic role for the assistance of vascular reactivity and treatment of neurodegenerative diseases associated with cognitive disturbances, such as Alzheimer’s disease.(14,15) High-sensitivity C-reactive protein (hs-CRP), an acute inflammatory biomarker, has a critical role in our immune system.”
BackgroundLi, K., Liu, F., He, C.-X., Huang, H., Xie, A., Hu, F., Liu, D., Wang, J., & Zhu, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9007-z · Cited by 15
Neonatal Neurodegeneration in Alzheimer’s Disease Transgenic Mouse Model
Mazi, A. R., Arzuman, A. S., Gürel, B., Şahin, B., Tüzüner, M. B., Ozansoy, M., & Baykal, A. T. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170049 · Cited by 14
Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?
Nyarko, J. N. K., Quartey, M. O., Baker, G. B., & Mousseau, D. D. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718772514 · Cited by 12
Alasady, M. J., & Mendillo, M. L. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.10.006 · Cited by 16
Chittoor-Vinod, V. G., Bazick, H., Todd, A. G., Falk, D. J., Morelli, K. H., Burgess, R. W., Foster, T. C., & Notterpek, L. M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00105 · Cited by 12
Yurinskaya, M. M., Mitkevich, V. A., Barykin, E. P., Garbuz, D. G., Evgen’ev, M. B., Makarov, A. А., & Винокуров, М. Г. (2015) · Molecular Biology · doi:10.1134/s0026893315060230 · Cited by 11
Self-citationHeat Therapy: Targeting Health, Disease, and Disability
Richey, R. E., Hyldahl, R. D., Kaiser, B. W., Geiger, P. C., Halliwill, J. R., & Minson, C. T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70089 · Cited by 12
Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy
Bhatia, T. N., Clark, R. N., Needham, P. G., Miner, K. M., Jamenis, A. S., Eckhoff, E. A., Abraham, N., Hu, X., Wipf, P., Luk, K. C., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01114-6 · Cited by 11
Arispe, N. J., & Maio, A. D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180161 · Cited by 11
“Finally, there is extensive evidence that hsps protect cells from A (cid:2) peptide toxicity [53–59].”
Ohizumi, Y. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00245 · Cited by 12
Юринская, М. М., Mitkevich, V. A., Barykin, E. P., Garbuz, D. G., Евгеньев, М. Б., Makarov, A. А., & Винокуров, М. Г. (2015) · Molecular Biology · doi:10.7868/s0026898415060233 · Cited by 10
Self-citationXie, Y., Huang, J., & Chen, Y. (2022) · Brain and Behavior · doi:10.1002/brb3.2861 · Cited by 9
Vinokurov, A. Y., Palalov, A. A., Kritskaya, K. A., Demyanenko, S. V., Garbuz, D. G., Evgen’ev, M. B., Esteras, N., & Abramov, A. Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04077-9 · Cited by 12
“Previous studies suggested that exogenous HSP70 diffusion into the cells depends on the cell type [21] and the most available data indicates the perinuclear zone localization of eHSP70 in brain cells under stress conditions [21, 22], similar to the localization of the endogenous HSP70 [34].”
BackgroundSelf-citationGarbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2019) · Molecular Biology · doi:10.1134/s0026898419020058 · Cited by 9
Self-citationHeat shock protein 70 in Alzheimer's disease and other dementias: A possible alternative therapeutic
Valle-Medina, A., Calzada‐Mendoza, C. C., Ocharan-Hernández, M. E., Jiménez‐Zamarripa, C. A., & Juárez‐Cedillo, T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307021 · Cited by 12
“47 It would be interesting to consider whether a single agent aimed at increasing HSP70 expression has the desired effectiveness given its mechanism with the disease, or if various targeted agents complement the effect of HSP70.”
Heat shock proteins: a history of study in Russia
Евгеньев, М. Б. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01219-z · Cited by 7
Khalaf, N. B. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1711422 · Cited by 9
Removal of the Olfactory Bulbs in Mice Leads to Changes in Affective Behavior
Nedogreeva, O. A., Stepanichev, M. Y., & Gulyaeva, N. V. (2020) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-020-00982-3 · Cited by 7
Nelson, V. K., Begum, M. Y., Dera, A. A., Ali, S. P., & Suryadevara, P. R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178034 · Cited by 6
A Mouse Model of Sporadic Alzheimer’s Disease with Elements of Major Depression
Бобкова, Н. В., Chuvakova, L. N., Kovalev, V. I., Zhdanova, D. Y., Chaplygina, A. V., Rezvykh, A. P., & Evgen’ev, M. B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04346-7 · Cited by 6
“It should be noted that OBX mice and rats are often considered in the literature as a valid model of depression [26, 114, 115].”
Self-citationMorozov, A. V., Yurinskaya, M. M., Mitkevich, V. A., Garbuz, D. G., Преображенская, О. В., Винокуров, М. Г., Evgen’ev, M. B., Карпов, В. Л., & Makarov, A. А. (2017) · Molecular Biology · doi:10.1134/s0026893316060133 · Cited by 5
Self-citationExogenous Hsp70 attenuates nitroglycerin-induced migraine-like symptoms in mice
Wu, F., Huang, Y., Wei, G., Huang, Z., Shi, C., Lin, W., & Liao, J. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00314.2021 · Cited by 5
Mechanistic insights of molecular chaperone Hsp70: Pathogenesis of neurodegenerative diseases
Choudhary, A., Kumar, P., Jagtap, Y. A., Kinger, S., Jha, H. C., Gutti, R. K., Sharma, V., Prajapati, V. K., & Mishra, A. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.05.001 · Cited by 6
Regulation of translation elongation and integrated stress response in heat-shocked neurons
Seluzicki, C. M., Razavi-Mohseni, M., Türker, F., Patel, P., Hua, B., Beer, M., Goff, L. A., & Margolis, S. S. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115639 · Cited by 6
Zhdanova, D., Бобкова, Н. В., Chaplygina, A. V., Svirshchevskaya, E. V., Полтавцева, Р. А., Vodennikova, A. A., Chernyshev, V. S., & Sukhikh, G. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094026 · Cited by 5
Using Single-Molecule Fluorescence Microscopy to Uncover Neuronal Vulnerability to Protein Damage
Jacob‐Tomas, S., Boopathy, L. R. A., & Vera, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_15 · Cited by 4
Metadata
- Authors
- Bobkova, N. V., Garbuz, D. G., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Yashin, V., Karpov, V., Kukharsky, M. S., Ninkina, N. N., Smirnov, A. A., Nudler, E., & Evgen'ev, M.
- Affiliations
- Institute of Cell Biophysics, RAS, Pushchino, Moscow region, Russia
- Engelhardt Institute of Molecular Biology (RU)
- Institute of Cell Biophysics (RU)
- Engelhardt Institute of Molecular Biology, Moscow, Russia
- Institute of Physiologically Active Compounds (RU)
- Cardiff University (GB)
- Institute of Theoretical and Experimental Biophysics (RU)
- New York University (US)
- Corresponding author
- Nudler, Evgeny
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2013-11-13
- Volume
- 38
- Issue
- 2
- Pages
- 425-435
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1899777911
- Cited by
- 138
- References
- 45
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 7 · 2019: 12 · 2018: 14 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 7 · 2013: 1
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Funders
- Bethlehem Griffiths Research Foundation
- Russian Foundation for Basic Research
- Dynasty Foundation
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- HSP70, Alzheimer's disease
- MeSH terms
- Administration, Intranasal, Alzheimer Disease, Animals, Olfaction Disorders, Cerebral Cortex, Disease Models, Animal, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Olfactory Bulb, Amyloid beta-Protein Precursor, HSP70 Heat-Shock Proteins, Mice, Presenilin-1, Amyloidogenic Proteins, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.